61 – 70 of 257
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Fractional exhaled breath temperature in patients with asthma, chronic obstructive pulmonary disease, or systemic sclerosis compared to healthy controls
(
- Contribution to journal › Article
-
Mark
The need for clean air : The way air pollution and climate change affect allergic rhinitis and asthma
(
- Contribution to journal › Scientific review
- 2019
-
Mark
Quality standards in respiratory real-life effectiveness research : The REal Life EVidence AssessmeNt Tool (RELEVANT): Report from the Respiratory Effectiveness Group - European Academy of Allergy and Clinical Immunology Task Force
(
- Contribution to journal › Article
-
Mark
The REal Life EVidence AssessmeNt Tool (RELEVANT) : Development of a novel quality assurance asset to rate observational comparative effectiveness research studies
(
- Contribution to journal › Article
-
Mark
Comparing biologicals and small molecule drug therapies for chronic respiratory diseases : An EAACI Taskforce on Immunopharmacology position paper
(
- Contribution to journal › Article
-
Mark
IL-33 drives influenza-induced asthma exacerbations by halting innate and adaptive antiviral immunity
(
- Contribution to journal › Article
-
Mark
Mast Cell-Mediated Orchestration of the Immune Responses in Human Allergic Asthma : Current Insights
(
- Contribution to journal › Article
-
Mark
Osteopontin protects against pneumococcal infection in a murine model of allergic airway inflammation
(
- Contribution to journal › Article
-
Mark
Clinical validation of the Swedish version of Dyspnoea-12 instrument in outpatients with cardiorespiratory disease
(
- Contribution to journal › Article
-
Mark
IL-33 blockade affects mediators of persistence and exacerbation in a model of chronic airway inflammation
(
- Contribution to journal › Article